Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Isotretinoin Capsules
NCT02498288Phase 1Completed
- Sponsor
- GSK
- Start
- May 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of isotretinoin in acne vulgaris, sponsored by GSK. Primary endpoints: Area under the plasma concentration-time curve from zero hours to last quantifiable time, Area under the plasma concentration-time curve from zero hours to infinite and 2 more. Started May 2013; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02498288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02498288.